SIMM

PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT

Retrieved on: 
Tuesday, December 20, 2022
Hospital, Severe acute respiratory syndrome coronavirus 2, Ritonavir, Neuropsychiatric Disease and Treatment, SIMM, Chinese Academy of Sciences, Patient, National Medical Products Administration, Trial of the century, Clinical trial, Central nervous system, Phase, Simcere Pharmaceutical, Drug discovery, Biotechnology, Capacity building, Fatality, Health, Degenerative disease, III, China-Japan Friendship Hospital, COVID-19, Medicine, Technology transfer, Safety, Post-exposure prophylaxis, National Center for Advancing Translational Sciences, Peking Union Medical College, Infection, Wuhan Institute of Virology, WIV, Cancer, NDA, Fear, FPI, Viral load, New Drug Application, Wuhan Jinyintan Hospital, Research, CAS, Pharmaceutical industry, Materia medica, Study, Virology

Simcere will accelerate the analysis of clinical study results and actively prepare for New Drug Application (NDA), while speeding up the expansion of production capacity to meet urgent clinical needs.

Key Points: 
  • Simcere will accelerate the analysis of clinical study results and actively prepare for New Drug Application (NDA), while speeding up the expansion of production capacity to meet urgent clinical needs.
  • This is to fulfill the Group's corporate mission of "providing today's patients with medicines of the future".
  • The Study has established a total of 43 clinical research centers in 20 provinces, municipalities and autonomous regions in China.
  • XIANNUOXIN is a combination packaged drug of a small molecule anti- SARS-CoV-2 drug candidate and Ritonavir, this candidate is targeted 3CL protease which is essential for SARS-CoV-2 viral replication.

Crave InfoTech wins 'Best Warehouse and Automation Company' at Inflection Awards

Retrieved on: 
Tuesday, June 21, 2022
Solution, SAP, Robotic process automation, Association, CEO, Excellence, IOT, Zebra Technologies, Warehouse, Supply, RFID, Council, SIMM, Crave, Partnership, BTP, Automation, Internet of things, RPA, AI, Intelligent enterprise, Machine learning

Crave InfoTech won the award for its work with a leading global life science/pharmaceutical client .

Key Points: 
  • Crave InfoTech won the award for its work with a leading global life science/pharmaceutical client .
  • Crave's product cWarehouse was central in its overall Intelligent Warehouse Management solution for the life science enterprise.
  • Shrikant Nistane, CEO, Crave InfoTech, said, "It's an honor to be felicitated by our peers for our Intelligent Supply Chain and Warehouse Management products.
  • Crave InfoTech is a SAP Business Technology Partner expert with multiple satisfied clients within the life science or pharmaceutical industry.

Finastra and CloudMargin Collateral Management as a Service offering accelerates compliance with UMR regulation

Retrieved on: 
Thursday, March 24, 2022
Ownership, Software, Solution, Finastra, ISDA, Treasury, Software as a service, UMR, CEO, Partnership, EVP, SIMM, Security (finance)

LONDON, March 24, 2022 /PRNewswire/ -- Finastra today announced that its Collateral Management as a Service app – powered by CloudMargin and available through Finastra's FusionFabric.cloud platform ­– now incorporates new capabilities to help financial institutions meet the requirements for Uncleared Margin Rules (UMR).

Key Points: 
  • For firms not familiar with posting initial margin, getting ready for UMR can be a significant, time-intensive process.
  • The partnership between Finastra and CloudMargin will make it easy for Finastra customers using solutions such as Fusion Kondor, Fusion Opics and Fusion Summit to submit the data needed to comply.
  • Together with CloudMargin, we're offering our customers a solution that is cost efficient and quick to adopt.
  • Delivering collateral management as a service, rather than deploying on-premise software, dramatically reduces the cost of ownership for users and delivers fast results."

Finastra and CloudMargin Collateral Management as a Service offering accelerates compliance with UMR regulation

Retrieved on: 
Thursday, March 24, 2022
Ownership, Software, Solution, Finastra, ISDA, Treasury, Software as a service, UMR, CEO, Partnership, EVP, SIMM, Security (finance)

LONDON, March 24, 2022 /PRNewswire/ -- Finastra today announced that its Collateral Management as a Service app – powered by CloudMargin and available through Finastra's FusionFabric.cloud platform ­– now incorporates new capabilities to help financial institutions meet the requirements for Uncleared Margin Rules (UMR).

Key Points: 
  • For firms not familiar with posting initial margin, getting ready for UMR can be a significant, time-intensive process.
  • The partnership between Finastra and CloudMargin will make it easy for Finastra customers using solutions such as Fusion Kondor, Fusion Opics and Fusion Summit to submit the data needed to comply.
  • Together with CloudMargin, we're offering our customers a solution that is cost efficient and quick to adopt.
  • Delivering collateral management as a service, rather than deploying on-premise software, dramatically reduces the cost of ownership for users and delivers fast results."

Cassini Systems Named Best UMR Service of the Year in Risk Markets Technology Awards 2022

Retrieved on: 
Friday, February 18, 2022
OMS, AANA, Adoption, UMR, CEO, NEW, Movement, BlackRock, Tier 1, Efficiency, SIMM, Compliance, View, Aladdin, Multimedia, Industry, Margin (finance), Security (finance), Cassini

LONDON, NEW YORK and SINGAPORE, Feb. 18, 2022 /PRNewswire/ -- Cassini Systems ,the leading provider of pre- and post-trade margin and collateral analytics for derivatives market participants and specialist in Uncleared Margin Rules (UMR) compliance, has just won the 2022 Risk Markets Technology Award for Best UMR Service of the Year.

Key Points: 
  • LONDON, NEW YORK and SINGAPORE, Feb. 18, 2022 /PRNewswire/ -- Cassini Systems ,the leading provider of pre- and post-trade margin and collateral analytics for derivatives market participants and specialist in Uncleared Margin Rules (UMR) compliance, has just won the 2022 Risk Markets Technology Award for Best UMR Service of the Year.
  • Liam Huxley, CEO and founder at Cassini Systems, said: "We are thrilled that our fully embedded solution has been recognized by Risk.net.
  • A judging panel consisting of technology users and Risk.net editors select the winners of the Risk Markets Technology Awards.
  • Our tools help them reduce collateral liquidity risk, lower the cost of financing trades, and understand how and where capital is being consumed."

Cassini Systems Named Best UMR Service of the Year in Risk Markets Technology Awards 2022

Retrieved on: 
Friday, February 18, 2022
OMS, AANA, Adoption, UMR, CEO, NEW, Movement, BlackRock, Tier 1, Efficiency, SIMM, Compliance, Aladdin, Industry, Margin (finance), Security (finance), Cassini

 LONDON, NEW YORK and SINGAPORE, Feb. 18, 2022 /PRNewswire/ -- Cassini Systems, the leading provider of pre- and post-trade margin and collateral analytics for derivatives market participants and specialist in Uncleared Margin Rules (UMR) compliance, has just won the 2022 Risk Markets Technology Award for Best UMR Service of the Year.

Key Points: 
  • LONDON, NEW YORK and SINGAPORE, Feb. 18, 2022 /PRNewswire/ -- Cassini Systems ,the leading provider of pre- and post-trade margin and collateral analytics for derivatives market participants and specialist in Uncleared Margin Rules (UMR) compliance, has just won the 2022 Risk Markets Technology Award for Best UMR Service of the Year.
  • Liam Huxley, CEO and founder at Cassini Systems, said: "We are thrilled that our fully embedded solution has been recognized by Risk.net.
  • A judging panel consisting of technology users and Risk.net editors select the winners of the Risk Markets Technology Awards.
  • Our tools help them reduce collateral liquidity risk, lower the cost of financing trades, and understand how and where capital is being consumed."

VERMEG's COLLINE Collateral Suite Adds New Margin Analytics Capabilities from Cassini Systems

Retrieved on: 
Thursday, January 6, 2022
SIMM, OTC, Digital transformation, Information, CCPS, Movement, Tier 1, Digital, Organization, Standardized approach (counterparty credit risk), Sehnde, OOTB, Software as a service, Efficiency, CEO, Capital market, UMR, Partnership, Automation, Treasury, Pressure, NEW, Solution, Multimedia, Industry, Security (finance), Online shopping, Insurance, Cassini

VERMEG has integrated Cassini's margin analytics platform into its COLLINE collateral suite, giving its clients a powerful new tool for achieving cost efficiencies and helping to meet requirements of the Uncleared Margin Rules (UMR).

Key Points: 
  • VERMEG has integrated Cassini's margin analytics platform into its COLLINE collateral suite, giving its clients a powerful new tool for achieving cost efficiencies and helping to meet requirements of the Uncleared Margin Rules (UMR).
  • The VERMEG-Cassini partnership provides clients with a comprehensive workflow for managing intraday and end-of-day collateral requirements centrally within COLLINE's standardized workflow inclusive of collateral optimization.
  • COLLINE is VERMEG's integrated platform for cross-product collateral management supporting cleared and uncleared derivatives in all asset classes.
  • It integrates into post-trade collateral management, treasury and risk systems enabling clients to bring post-trade cost analytics into the pre-trade process.

VERMEG's COLLINE Collateral Suite Adds New Margin Analytics Capabilities from Cassini Systems

Retrieved on: 
Thursday, January 6, 2022
SIMM, OTC, Digital transformation, Information, CCPS, Movement, Tier 1, Digital, Organization, Standardized approach (counterparty credit risk), Sehnde, OOTB, Software as a service, Efficiency, CEO, Capital market, UMR, Partnership, Automation, Treasury, Pressure, NEW, Solution, Industry, Security (finance), Insurance, Cassini

VERMEG has integrated Cassini's margin analytics platform into its COLLINE collateral suite, giving its clients a powerful new tool for achieving cost efficiencies and helping to meet requirements of the Uncleared Margin Rules (UMR).

Key Points: 
  • VERMEG has integrated Cassini's margin analytics platform into its COLLINE collateral suite, giving its clients a powerful new tool for achieving cost efficiencies and helping to meet requirements of the Uncleared Margin Rules (UMR).
  • The VERMEG-Cassini partnership provides clients with a comprehensive workflow for managing intraday and end-of-day collateral requirements centrally within COLLINE's standardized workflow inclusive of collateral optimization.
  • COLLINE is VERMEG's integrated platform for cross-product collateral management supporting cleared and uncleared derivatives in all asset classes.
  • It integrates into post-trade collateral management, treasury and risk systems enabling clients to bring post-trade cost analytics into the pre-trade process.

Bloomberg Introduces Pre-Trade SIMM Calculations to Support Phase 6 Initial Margin UMR Adherence

Retrieved on: 
Wednesday, December 8, 2021
Solution, Twitter, Risk, API, Technology, International Organization of Securities Commissions, IOSCO, XVA, Republika Srpska Securities Commission, News, Efficiency, Industry, Organization, ISDA, Bloomberg Terminal, Basel Committee on Banking Supervision, Vanilla, Multimedia, SIMM, CRIF, International, Risk management, LinkedIn, Bloomberg, Cryptocurrency, Security (finance)

The new calculations enable clients to run pre-trade SIMM analytics through Bloomberg's Multi Asset Risk Solutions (MARS) using Acadia's IMEM CRIF data capabilities.

Key Points: 
  • The new calculations enable clients to run pre-trade SIMM analytics through Bloomberg's Multi Asset Risk Solutions (MARS) using Acadia's IMEM CRIF data capabilities.
  • MARS SIMM is an optimization tool that allows traders to improve their front office decision making in light of the current Uncleared Margin Rule framework.
  • The integration enables clients to run SIMM pre-trade analytics through MARS SIMM using Acadia's Initial Margin Exposure Manager (IMEM) CRIF capabilities.
  • Since 2018, the service has enabled market participants in-scope for the calculation of initial margin for uncleared derivatives access to risk sensitivities calculation services both through Bloomberg and Acadia.

Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments

Retrieved on: 
Tuesday, November 23, 2021
Patient, Shanghai Institute of Technology, Lists of diseases, Chinese Academy of Sciences, CEO, Safety, Degenerative disease, Autoimmune disease, Cancer, Severe acute respiratory syndrome coronavirus 2, SIMM, Simcere Pharmaceutical, CAS, COVID-19, History, Research, Sincerity, Biotechnology, Neuropsychiatric Disease and Treatment, Drug development, Peripheral nervous system, Infection, Method, Disease, Drug discovery, Pharmaceutical industry

Under the arrangement, Simcere will obtain the exclusive right to develop, manufacture and commercialize the novel antiviral drug SIM0417 globally.

Key Points: 
  • Under the arrangement, Simcere will obtain the exclusive right to develop, manufacture and commercialize the novel antiviral drug SIM0417 globally.
  • SIM0417 is a small-molecule antiviral agent that targets the 3C-like protease, a key enzyme in the replication and life cycle of coronaviruses, including SARS-CoV-2.
  • Mr. Ren Jinsheng, Chairman and CEO of Simcere commented, "R&D collaboration is one of our 'dual-track'-based R&D strategies.
  • About Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    The Shanghai Institute of Materia Medica (SIMM) of the Chinese Academy of Sciences (CAS) was founded in 1932, and has the longest history as a comprehensive research institution for drug discovery in China.